ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
Dow Jones
42,992.21
-0.77%
US Dollar vs MXN
20.3272
0.00%
Brent Oil
73.44
0.00%
Bitcoin
95,017.21
0.91%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Connect Biopharma Holdings Inc (CNTB)

  7. Connect Biopharma Holdings Inc (CNTB) Noticias

CNTB

Connect Biopharma (CNTB)

Connect Biopharma Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CNTB
FechaHoraFuenteTítuloSímboloCompañía
23/12/202415:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
15/10/202406:30GlobeNewswire Inc.Attovia Therapeutics Appoints Chief Financial OfficerNASDAQ:CNTBConnect Biopharma Holdings Inc
10/09/202407:00GlobeNewswire Inc.Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024NASDAQ:CNTBConnect Biopharma Holdings Inc
05/09/202415:05GlobeNewswire Inc.Connect Biopharma Reports First Half 2024 Financial Results and Provides Business UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
27/02/202420:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
13/02/202415:30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:CNTBConnect Biopharma Holdings Inc
13/02/202415:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
23/06/202315:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
11/04/202315:59Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CNTBConnect Biopharma Holdings Inc
11/04/202315:05GlobeNewswire Inc.Connect Biopharma Reports Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
18/03/202313:40Business WireConnect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient SymptomsNASDAQ:CNTBConnect Biopharma Holdings Inc
17/03/202315:05Business WireConnect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body RegionsNASDAQ:CNTBConnect Biopharma Holdings Inc
06/03/202307:15Business WireConnect Biopharma CBP-201 Atopic Dermatitis Abstracts from Two Trials Accepted for Presentation at the American Academy of Dermatology (AAD) Annual MeetingNASDAQ:CNTBConnect Biopharma Holdings Inc
14/02/202305:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNTBConnect Biopharma Holdings Inc
06/02/202307:30GlobeNewswire Inc.Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom CaliforniaNASDAQ:CNTBConnect Biopharma Holdings Inc
03/01/202315:32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNTBConnect Biopharma Holdings Inc
30/12/202206:30GlobeNewswire Inc.Connect Biopharma Provides Business and Clinical Development Program UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
19/12/202207:00GlobeNewswire Inc.Connect Biopharma to Present at the San Francisco Biotech Showcase in JanuaryNASDAQ:CNTBConnect Biopharma Holdings Inc
02/12/202216:00GlobeNewswire Inc.Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price RequirementNASDAQ:CNTBConnect Biopharma Holdings Inc
27/10/202215:05GlobeNewswire Inc.Connect Biopharma To Present at Upcoming Investor and Scientific ConferencesNASDAQ:CNTBConnect Biopharma Holdings Inc
05/10/202207:45TipRanksConnect Biopharma Holdings (CNTB) Receives a Buy from JefferiesNASDAQ:CNTBConnect Biopharma Holdings Inc
04/10/202207:56GlobeNewswire Inc.CORRECTING and REPLACING -- Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in ChinaNASDAQ:CNTBConnect Biopharma Holdings Inc
04/10/202206:00GlobeNewswire Inc.Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in ChinaNASDAQ:CNTBConnect Biopharma Holdings Inc
03/10/202215:10GlobeNewswire Inc.Connect Biopharma to Host a Conference Call Tuesday, October 4 to Discuss Topline Results for the Pivotal Trial in China of Lead Candidate, CBP-201, in Patients with Moderate-to-Severe Atopic DermatitisNASDAQ:CNTBConnect Biopharma Holdings Inc
13/09/202215:05GlobeNewswire Inc.Connect Biopharma Reports First Half 2022 Financial Results and Provides Business UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
01/09/202207:00GlobeNewswire Inc.Connect Biopharma to Report First Half 2022 Financial Results on September 13NASDAQ:CNTBConnect Biopharma Holdings Inc
30/08/202207:00GlobeNewswire Inc.Connect BioPharma Successfully Completes CBP-174 Phase 1 Single Ascending Dose StudyNASDAQ:CNTBConnect Biopharma Holdings Inc
14/07/202201:18TipRanksSVB Securities Thinks Connect Biopharma Holdings’ Stock is Going to RecoverNASDAQ:CNTBConnect Biopharma Holdings Inc
11/07/202215:05GlobeNewswire Inc.Connect Moves Forward CBP-201 Top-Line Results Timeline for Pivotal China Atopic Dermatitis Trial to Second Half 2022NASDAQ:CNTBConnect Biopharma Holdings Inc
07/07/202205:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNTBConnect Biopharma Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CNTB

Su Consulta Reciente

AMEX
SPY
SPDR S&P 500
NYSE
NKE
Nike
NYSE
VZ
Verizon Communications
FX
EURMXN
Euro vs MXN
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLF
Financial Select Sector
CCOM
US30
US 30
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
COIN
ETHUSD
Ethereum
USOTC
BASFY
BASF (QX)
COIN
DOGEUSD
Dogecoin
NYSE
BAC
Bank of America
CCOM
US500
US 500
SPI
SP500
S&P 500
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados